logo
Why you shouldn't be afraid of the sun this summer: The health benefits of sunshine

Why you shouldn't be afraid of the sun this summer: The health benefits of sunshine

Independent10-07-2025
Many people worry that spending too much time in the hot summer sun could have serious consequences.
And it's true that people are at a heightened risk of skin damage, sun poisoning, melanoma, and other maladies during the season. However, feeling the sun's warm rays also comes with potentially unexpected benefits.
'The 'never go outside without S.P.F. 50' approach treated sun exposure as if it were universally harmful,' Dr. Lucy McBride, an internal medicine physician in Washington, D.C., told The New York Times. However, 'moderate, thoughtful sun exposure,' in accordance with personal risk factors, she added, 'may offer benefits we're still discovering.'
Here's what to know before your next trip to the park or the beach.
The benefits
Exposure to sunshine has been linked to lower blood pressure, regardless of the temperature. And while that study published in the Journal of the American Heart Association was observational, one doctor said its findings could prove beneficial.
Another study, published in the Journal of the American Heart Association, found moderate exposure to sunlight may be a prevention strategy for heart failure.
It's not just heart health that sees a benefit.
A group of German scientists at Münster University found that the sun's ultraviolet B rays -- the ones responsible for melanoma -- support the build-up of a healthy immune system and protect the central nervous system.
Professor Karin Loser said that a similar effect, in the case of other diseases, is already known. Research has shown that ultraviolet light exposure can improve symptoms in people with eczema, and experts prescribe light therapy to treat psoriasis.
"From our treatment of psoriasis," she said, "we know that ultraviolet light has a positive effect on the immune system."
The drawbacks
Still, there are some serious risks to spending too much time outside.
For one, any tan you may get is a sign of skin damage. Sunburn can lead to sun poisoning, which may result in blisters that cause skin infection.
In addition, skin cancer remains the most common form of cancer in the U.S. Nearly 20 Americans die from melanoma every day, according to the American Academy of Dermatology Association.
'Everyone's skin can be impacted by the sun and other forms of UV rays – regardless of their skin color,' Dr. Shanthi Sivendran, senior vice president at the American Cancer Society, said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Roche to investigate whether new drug can delay or prevent Alzheimer's disease
Roche to investigate whether new drug can delay or prevent Alzheimer's disease

Reuters

timean hour ago

  • Reuters

Roche to investigate whether new drug can delay or prevent Alzheimer's disease

July 27 (Reuters) - Swiss drugmaker Roche Holding (ROG.S), opens new tab plans to investigate whether an experimental medicine can delay or prevent Alzheimer's disease symptoms, it said on Sunday, as a part of the company's growing development programme for the disease. The clinical trial of the drug, Trontinemab, will target people who are at risk of cognitive decline and will aim to delay or prevent the symptoms of Alzheimer's, Roche said in a statement. Trontinemab is designed so that the drug is transported across the blood brain barrier—protective blood vessels that prevent chemicals in the bloodstream from entering the brain — in hopes of delivering more of the treatment to the brain. Rivals like Eli Lilly (LLY.N), opens new tab have been making progress in the complicated field of Alzheimer's recently, with Lilly's drug Kisunla getting a recommendation for approval for certain patients from the European Medicines Agency last week. Kisunla is already approved in the U.S. Treatments for Alzheimer's approved so far, including Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab Leqembi and Lilly's Kisunla, are designed to clear sticky clumps of a protein called amyloid beta in the brain. They carry hefty price tags as well as the risk of serious brain swelling and bleeding.

Roche to test if new drug can prevent Alzheimer's disease, Bloomberg News reports
Roche to test if new drug can prevent Alzheimer's disease, Bloomberg News reports

Reuters

time2 hours ago

  • Reuters

Roche to test if new drug can prevent Alzheimer's disease, Bloomberg News reports

July 27 (Reuters) - Swiss drugmaker Roche Holding (ROG.S), opens new tab plans to test whether an experimental medicine can prevent Alzheimer's disease symptoms in high-risk people, Bloomberg News reported on Sunday. The new late-stage study will target people who are at risk of cognitive decline and aim to slow down the emergence of symptoms or prevent them fully, the report said, citing a statement. The new pre-clinical study is the third largest late-stage trial that the company has announced for its drug trontinemab, which uses an experimental technology called brain shuttle to ferry medicine past the protective blood-brain barrier, according to the report. Rivals like Eli Lilly (LLY.N), opens new tab have been making progress in the complicated field of Alzheimer's recently with Lilly's Alzheimer's drug Kisunla getting recommendation from the European Medicines Agency (EMA) last week. Reuters could not immediately verify the report. Roche did not immediately respond to a request for a comment. Treatments for Alzheimer's approved so far, including Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab Leqembi, and Eli Lilly's Kisunla, are designed to clear sticky clumps of a protein called amyloid beta in the brain. They also carry hefty price tags and the risk of serious brain swelling and bleeding.

Hospital begs for help identifying woman who has been in their care for past 100 days
Hospital begs for help identifying woman who has been in their care for past 100 days

Daily Mail​

time3 hours ago

  • Daily Mail​

Hospital begs for help identifying woman who has been in their care for past 100 days

A Manhattan hospital is begging for the public's help in identifying a woman who was admitted more than 100 days ago. On April 12 around 4:45am, a woman believed to be in her late-fifties was sitting at a Harlem bus stop when a bystander dialed 911. It is unclear why an ambulance was called, but she was taken to Mount Sinai in Morningside Heights - where she has remained ever since. Employees have described the mysterious patient, who may go by the name Pam, as shy. In a photo shared by the hospital, she was seen covering her face with a towel. But these surface-level details are all officials have gathered about Pam during her three months at the hospital, and now hospital workers are trying to fill in the gaps. The hospital is asking anyone with information on who she might be to come forward, NBC reported. Pam is 5'8" tall and weighs 170 pounds. Hospital workers believe she was often in the Harlem area and generally wore black and covered her face. She speaks English and has greying hair. The Daily Mail has reached out to Mount Sinai for comment. Anyone with information regarding Pam's identity should contact the hospital's associate director of social work Kelly LaTerra at 646-901-9309. Last month, a California man was found unconscious and was rushed to St. Mary Medical Center in Long Beach. He was believed to be in his mid-forties, but just as in Pam's case, little else was known about the patient. A chilling photo released by Dignity Health showed the man lying in a hospital bed, hooked up to a ventilator. In October 2024, another California hospital took a similar approach to Mount Sinai in hopes of identifying a seriously ill patient. Staff at the Riverside Community Hospital had done everything they could think of, but could not determine the name of a man who came through the facility's doors a month earlier. They refused to say what was wrong with him or why he was attached to a ventilator, but released a photograph in the hopes that someone can put a name to the face. Identifying John or Jane Doe patients is no easy task, as doctors and other hospital staff members must work to find out who they are without violating their rights. The New York Department of Health has protocols in place specifically for missing children, college students and vulnerable adults. These standards were set in 2018 after 'several instances of a missing adult with Alzheimer's disease who was admitted to a hospital as an unidentified patient and police and family members were unable to locate the individual.' However, the process is not as cut and dry when it is the hospital asking for the public's help instead of the other way around. While hospitals have been known to share images of unknown patients when all else fails, they are not allowed to reveal much about their circumstances.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store